|
|
|
|
 |
M&A
As part of our M&A strategy, Æterna Zentaris is always looking for new compounds that will have reached the latest development stage possible in our core therapeutic areas.
We are also looking on an ongoing basis for activities and discussions that could lead to the purchase of a company that would fall in the following strategic acquisition criteria:
- excellent scientific rationale;
- late-stage development;
- well-patented technology;
- strong management team;
- healthy financial position and
- existing partnership.
To enquire about partnering opportunities (in- or out-licensing), please contact our business development group:
Chantal Gravel
Director, Business Operations
Phone: (418) 652-8525, ext. 362
cgravel@aezsinc.com
|
 |
|
|
 |
